Home       Market Dynamics     Macro Trends     Sector Trends     Company Insights     AI Investing     Strategies     Sign Up     Login         

Novartis AG (NVS) Stock Price Prediction and News Highlight
Tue. Sep 1, 2026

One Week Return: 0.78%, One Month Return: 3.27%, Three Month Return: 10.68%

Sector: Pharmaceuticals

Novartis AG is experiencing mixed outcomes in its product development efforts. Positive results from Phase III trials of remibrutinib for Multiple Sclerosis are generating optimism around their pipeline, complemented by promising data for a potential blockbuster product. However, the recent halt in clinical trials for a key product could pose challenges to future growth. The balance of these factors will be crucial in shaping the company's product development landscape.

The price action of Novartis AG (NVS) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 0.9 is bullish. The market sentiment at -0.6 is bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for NVS since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.9, and the negative at -1.5 on 2026-09-01. The forces of Market Risk Appetite (3.1), Option Sentiment (1.5), Stock Price Trend (0.9), and Sector Price Trend (0.1) will drive up the price. The forces of Price Level Sentiment (-0.5), Sentiment towards Fundamentals (-3.9), and Valuation Sentiment (-4.4) will drive down the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-10-27 06:30, EPS: $8.69, P/E: 18.56

Sign up to reveice notifications on Market Movers
NVS
DateAttentionPriceStdDevPrice
Level
RSIHourly
RSI
Change10 Day
Trend
Trend
Sentiment
Hourly
Trend
Sentiment
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2026-09-010%(0%)      161.25 1.85%    98    62   80   6.04%    0.45% 0.9    0.9    2.7%    -0.5    Wait    50% -3.9    5   
2026-08-310%(0%)      152.06 1.79%    22    46   39   -1.14%    0% -0.5    -0.2    0.7%    -0.7    Short    55% -3.2    -1   
2026-08-300%(0%)    -0.2    -0.2    -1.2          -3.4    -1   
2026-08-290%(0%)    -0.2    -0.2    -1.2          -3.4    -1   
2026-08-280%(0%)      153.81 1.72%    37    45   35   -0.54%    0.19% -0.2    -0.2    1.1%    -0.9    Short    55% -3.4    -1   
2026-08-270%(0%)      154.65 1.71%    44    47   13   -1.84%    0.19% 0    -0.3    1.3%    -0.1    Short    55% -1.5    -1   
2026-08-260%(0%)      157.55 1.73%    69    56   35   -1.54%    0.32% -0    -0.1    0.6%    0.4    Short    55% -0.8    -1   
2026-08-250%(0%)      160.01 1.74%    90    60   75   1.25%    0.32% 0.7    0.1    0.5%    1.5    Long    55% 1.2    -1   
2026-08-240%(0%)      158.03 1.75%    72    59   41   -0.53%    0.13% 0.6    -0.1    0.6%    1.7    Wait    50% 2.1    -1   
2026-08-230%(0%)    0.7    -0.1    2.5          3.1    -1   
 
Wait is the preferred trading strategy with 50% chance of being right.

Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.

Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

  Analysis
● Novartis AG (NVS) Equity Research Report Wed. Mar 11, 2026

2026-09-01 22:47:49 The shares of Novartis have seen a noticeable increase due to favorable trial data, indicating strong market confidence.
2026-09-01 22:47:49 Positive outcomes from clinical trials, particularly related to Novartis' drug for multiple sclerosis, have resulted in significant stock price increases.
2026-09-01 17:07:55 Novartis' achievements in developing new treatments for Multiple Sclerosis are positioning the company favorably against competitors.
2026-09-01 17:07:55 The decision to pause trials raises questions about the regulatory landscape and concerns regarding the safety of experimental treatments.
2026-09-01 17:07:55 The suspension of clinical trials following patient deaths casts a shadow over the company's trial processes and could affect future developments.
2026-09-01 17:07:55 Novartis' stock has reacted positively to recent trial results, showcasing a significant increase in its stock value.
2026-09-01 17:07:55 Several articles highlight the encouraging results from Novartis' remibrutinib in Phase III trials, showing promise for Multiple Sclerosis treatment.
2026-09-01 13:46:53 The positive data for a different potential blockbuster product provides some reassurance regarding the company's pipeline.
2026-09-01 13:46:53 The pause in clinical trials for a key product could hinder future growth prospects in the short term.
2026-09-01 13:46:53 Despite the negative news, the stock is experiencing a recovery, indicating investor optimism about other positive developments.
2026-09-01 13:46:53 The report of patient deaths raises significant ethical and legal concerns regarding the clinical trials and their oversight.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA